Suppr超能文献

用于治疗心力衰竭的卡维地洛:对β受体阻滞剂的新关注。

Carvedilol for heart failure: renewed interest in beta blockers.

作者信息

Young J B

机构信息

Department of Cardiology, Cleveland Clinic, USA.

出版信息

Cleve Clin J Med. 1997 Sep;64(8):415-22. doi: 10.3949/ccjm.64.8.415.

Abstract

Although beta blockers were once contraindicated in patients with heart failure, a growing understanding of the role of the sympathetic nervous system in heart failure is rekindling interest in these drugs. In particular, the beta blocker carvedilol is a valuable adjunctive treatment for mild-to-moderate compensated congestive heart failure, regardless of etiology. The utility of carvedilol appears to be related to its specific properties.

摘要

尽管β受体阻滞剂曾被列为心力衰竭患者的禁忌药物,但对交感神经系统在心力衰竭中作用的认识不断深入,重新燃起了人们对这些药物的兴趣。特别是,β受体阻滞剂卡维地洛是轻至中度代偿性充血性心力衰竭的一种有价值的辅助治疗药物,无论其病因如何。卡维地洛的效用似乎与其特定特性有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验